Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Mar 1;40(3):420-425.
doi: 10.1093/humrep/deaf006.

Ethical considerations on surrogacy†

Writing Group on behalf of the ESHRE Ethics Committee; Francoise Shenfield  1 , Basil Tarlatzis  2 , Guiliana Baccino  3 , Theofano Bounartzi  4 , Lucy Frith  5 , Guido Pennings  6 , Veerle Provoost  6 , Nathalie Vermeulen  7 , Heidi Mertes  6   8
Affiliations

Ethical considerations on surrogacy†

Writing Group on behalf of the ESHRE Ethics Committee et al. Hum Reprod. .

Abstract

Surrogacy is the assisted reproductive technology (ART) practice in which a person becomes pregnant, carries, and delivers a child on behalf of another couple/person, who are the intended parent(s). Surrogacy is an especially complex practice as the interests of the intended parents, the gestational carrier, and the future child may differ. This paper considers ethical questions related to different forms of surrogacy. It concludes that non-commercial surrogacy is an acceptable method of assisted reproduction for specific indications. When using surrogacy to form a family, it is essential that there are measures to protect all parties, to guarantee well-considered decision-making, and to minimize risks. The current paper formulates recommendations to promote these measures. This paper is an update to the ESHRE Task Force Ethics and Law Paper 10: Surrogacy and replaces this paper.

Keywords: ART; commissioning parents; enforceability; ethics; gestational carrier; intended parents; surrogate; third-party reproduction.

PubMed Disclaimer

Conflict of interest statement

None declared.

Figures

Figure 1.
Figure 1.
Overview of the key points related to surrogacy and the recommendations. Created using BioRender.com.
See this image and copyright information in PMC

References

    1. Alteri A, Arroyo G, Baccino G, Craciunas L, De Geyter C, Ebner T, Koleva M, Kordic K, Mcheik S, Mertes H et al. ; ESHRE Guideline Group on the Number of Embryos to Transfer. ESHRE guideline: number of embryos to transfer during IVF/ICSI. Hum Reprod 2024;39:647–657. - PMC - PubMed
    1. Amorado P, Magann EF, Phillips AM, Moutos DM, Whittington JR, Hughes DS, Klausen JH. Is a surrogate pregnancy a high-risk pregnancy? Obstet Gynecol Surv 2021;76:302–309. - PubMed
    1. BBC. Australian couple ‘did not reject Down’s baby’ Gammy. 2016. https://www.bbc.com/news/world-australia-36012320 (20 January 2025, date last accessed).
    1. Brandão P, Garrido N. Commercial surrogacy: an overview. Rev Bras Ginecol Obstet 2022;44:1141–1158. - PMC - PubMed
    1. Calhaz-Jorge C, Smeenk J, Wyns C, De Neubourg D, Baldani DP, Bergh C, Cuevas-Saiz I, De Geyter C, Kupka MS, Rezabek K et al. ; European IVF-Monitoring Consortium (EIM) for the European Society of Human Reproduction and Embryology (ESHRE). Survey on ART and IUI: legislation, regulation, funding, and registries in European countries—an update. Hum Reprod 2024;39:1909–1924. - PMC - PubMed

MeSH terms